Ending AIDS Requires Strategy, Funding
UNAIDS has set a goal of ending the epidemic by 2030 but a strategic plan and much funding are needed to achieve that goal.
December 1, 2014 — Voice of America
CDC: Most Americans who need HIV treatment aren’t getting it
About 1.2 million Americans have HIV. Most of them know that they’re positive—only 14 percent are undiagnosed. But among those who know their status, fewer than half get care, according to new data from the Centers for Disease Control.
December 1, 2014 — Bloomberg Businessweek
We Can’t Wait Five Years to See if the AIDS Response is on Track
UNAIDS’ recent global goals offer a meaningful vision of what the “end of AIDS” might really mean. Now it’s time to sit down, roll up our sleeves, write the plan to achieve them — and implement at scale, with increased pace and with urgency.
November 26, 2014 — Huffington Post
Birth Control HIV Risk?
Does the commonly used progesterone contraceptive injection increase the risk of a woman contracting HIV? This is what researchers hope to determine through a study involving thousands of women which is expected to start next year.
October 24, 2014 — Times (South Africa)
Acting Up for Ebola: International HIV activists launch solidarity call
As many pundits have observed, Ebola has freshly exposed the weakness of the global public health response, and of national health systems in poor countries. The key components of an effective emergency public health response — public education, rapid screening and treatment for disease, ethical access to drugs and vaccines, financing and leadership — are all in limited supply. As in the early days of AIDS, activists see too much politicking and a lack of overall coordination as the key problems, making them critical targets for protest.
October 23, 2014 — The Body
Will We Ever Know If This Widely-Used Contraceptive Increases the Risk of HIV Infection?
This article from the online science and technology magazine,The Verge, provides a clear, in-depth investigation into the proposed ECHO trial of contraception and HIV risk. An excellent overview on a complex, evolving topic.
October 21, 2014 — The Verge
UNAIDS plan to “Fast Track” end of AIDS means prioritizing men who have sex with men, people who inject drugs, sex workers, transgender people, women and girls
Fast Track, the strategy geared to ending the AIDS epidemic by 2030, which was outlined by UNAIDS at a side event to the United Nations General Assembly, notes that international efforts have produced impressive gains against HIV globally.
September 29, 2014 — Science Speaks
Advocates Call for Full Funding of Research on HIV and Contraception
A trial designed to evaluate how different methods of contraception (Depo, the copper IUD and the Jadelle implant) affect HIV risk is under-funded and in jeopardy—as explained in a new editorial authored by Lillian Mworeko of ICW-EA, AVAC Program Director Emily Bass, Tyler Crone, Johanna Kehler of the AIDS Legal Network South Africa, Sophie Dilmitis and Definate Nhamo of PGAT, Zimbabwe.
September 12, 2014 — RH Reality Check
Poor Data Imperils Global Effort to End AIDS
In a new report available atwww.endingaids.orgthis week, amfAR and AVAC call for the dramatic improvement of HIV/AIDS data collection, analysis and reporting. Data needs to be coordinated and accessible at more frequent intervals.
August 18, 2014 — The Hill
There’s a Pill That Prevents HIV — Why are Only Gay Men Talking About It?
A new editorial from an NYC-based digital journal focused on science and technology talks about the limited conversation about PrEP for women.
August 5, 2014 — The Verge
Got to Get Vaccinated!
AVAC Executive Director Mitchell Warren speaks on the importance of vaccination and how social media can help spread the message.
July 28, 2014 — Deutsche Welle
AIDS — Stepping up the Pace
Thirty-five million people worldwide carry the potentially deadly virus and some 20,000 children a month are newly infected. But with treatment and research making progress, some scientists are beginning to ask – is an AIDS-free generation within reach?
July 25, 2014 — Channel NewsAsia
The Missing Link
In 2013, 57 percent of people living with HIV were women. So why has the media frenzy around Truvada, a drug regime that could help prevent infection, excluded them?
July 23, 2014 — Foreign Policy
HIV Pill Truvada Shows More Promise Against Infection
Several concerns about a prescription drug used to prevent HIV infection in people at high risk are being put to rest by the results of new research. Follow-up from a landmark study showed the drug does not encourage risky sex and is effective even if people skip some doses.
July 22, 2014 — CBS News
Credibility Among Gay Men Gives Leverage to New York City’s New Chief of HIV Prevention
In his new role in charge of the Bureau of HIV/AIDS Prevention and Control, Demetre Daskalakis hopes that he will be able to leverage his acceptance among gay people to reach a population that has not always trusted authority.
July 21, 2014 — New York Times
AIDS Fight Among Casualties of Attack on Jetliner
A prominent AIDS researcher and five others headed to a medical meeting in Australia were confirmed killed in the crash of a Malaysia Airlines flight.
July 19, 2014 — Bloomberg BusinessWeek
Obama Praises AIDS Experts Killed in Malaysian Air Disaster
AIDS researchers and activists were stunned and horrified Friday to learn that prominent AIDS expert Dr. Joep Lange was among those killed aboard a Malaysian Airlines flight shot down over Ukraine on Thursday.
July 18, 2014 — NBC News
New Momentum on PrEP, But Needs are Overlooked
If the rest of the world follows America’s lead, PrEP could become an important global health success story. To realize PrEP’s potential, several specific things need to happen now.
July 17, 2014 — Huffington Post
Sex Without Fear
This expansive cover story examines the debate within the gay community over PrEP. There is excitement at the prospect of reduced fear of HIV transmission but some worry about a perceived potential for increased unprotected sex and its associated risks.
July 14, 2014 — New York Magazine
World Health Organization recommends men who have sex with men take PrEP to prevent HIV
The World Health Organization (WHO) has made a bold new recommendation that could have significant implications for the fight against HIV. All men who have sex with men (MSM), the guidelines suggest, should consider taking PrEP to help prevent HIV infection.
July 14, 2014 — Think Progress
With AIDS Vaccines, It’s Not “If” But “How”
Earlier this year, two global leaders in HIV prevention posed a provocative question: “Is an HIV vaccine necessary?” With so many other advances in HIV prevention occurring in the last few years, must we really keep heading down the long and difficult road to an effective vaccine?
May 19, 2014 — Huffington Post
Thanks for Nothing: iPrEX Volunteers Shut Out of PrEP’s Success
Most foreign volunteers who participated in the clinical trial that first proved Truvada prevents HIV no longer have access to the drug. Mitchell Warren, executive director of the global HIV advocacy group AVAC, says, “One of the top priorities has got to be—and we’ve raised this over and over again—that Gilead should be applying, at least for registration [of Truvada as PrEP], in each of the countries where any of the PrEP trials took place.”
May 2, 2014 — POZ
How Far We’ve Come In 30 Years Of HIV Research
David Hyde talks with Mitchell Warren about the breakthroughs and challenges of HIV prevention over the last 30 years. Warren said that one of the greatest breakthroughs in HIV-AIDS prevention was the rise of the citizen activism that pushed for funding, creativity and urgency in research. “AIDS really changed how research happened,” he said. “Science changed because communities ‘acted up.’”
April 29, 2014 — kuow.org
Narrow the Gulf Between HIV Prevention Research and Reality
People around the world have participated in clinical trials that have drastically changed the way we see HIV prevention. This has to be the year where we honor their commitment by following through on our promise to deliver proven options to the communities where they live.
March 12, 2014 — Huffington Post
ACT UP protests anti-gay laws at NYC’s Ugandan Consulate
Approximately 50 LGBTI activists protested outside the Ugandan Consulate decrying President Museveni’s passage of three Draconian measures.
March 6, 2014 — Edge San Francisco
FSN Reports
AVAC Executive Director Mitchell Warren speaks with Feature Story News about recent developments with long-acting injectables. One injection of anti-retrovirals was shown to protect lab monkeys from HIV for several weeks.
March 5, 2014 — Feature Story News
Injections providing protection against AIDS in monkeys, studies find
Researchers are reporting that injections of long-lasting AIDS drugs protected monkeys for weeks against infection, a finding that could lead to a major breakthrough in preventing the disease in humans.
March 4, 2014 — New York Times
Crowd-funded HIV vaccine project sparks debate
A tiny coffee shop table can barely contain Reid Rubsamen, whose restless energy nearly propels him out of his chair as he talks about the Immunity Project, his initiative to crowd-source money to make a new HIV vaccine.
February 10, 2014 — Nature
The POZ 100: 91 to 100
The bio of the executive director of AIDS Vaccine Advocacy Coalition (AVAC) says he “uses public education, policy analysis, advocacy and community mobilization to accelerate the ethical development and global delivery of AIDS vaccines and other HIV prevention options” (such as microbicides). We couldn’t say it better ourselves. So we didn’t try.
January 7, 2014 — POZ
→ Continue through the archives. Find articles from 2013 and older.